首页 | 本学科首页   官方微博 | 高级检索  
     


EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases,hepatobiliary cancer and liver transplant recipients
Authors:Markus Cornberg  Maria Buti  Christiane S. Eberhardt  Paolo Antonio Grossi  Daniel Shouval
Affiliation:1. Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany;2. Centre for Individualised Infection Medicine (CiiM), a joint venture of Helmholtz Centre for Infection Research and Hannover Medical School, Hannover, Germany;3. German Center for Infection Research (DZIF), Partner-Site Hannover-Braunschweig, Hannover, Germany;4. Liver Unit. Hospital Universitario Valle Hebron and Ciber-ehd del Instituto Carlos III, Barcelona, Spain;5. Center for Vaccinology, University Hospitals of Geneva and Faculty of Medicine, University of Geneva, Switzerland and Emory Vaccine Center, Emory University, Atlanta, GA, USA;6. Infectious and Tropical Diseases Unit, Department of Medicine and Surgery University of Insubria and ASST-Sette Laghi, Varese, Italy;7. Italian National Center for Transplantation, Rome, Italy;8. Liver Unit, Department of Medicine, Hadassah-Hebrew University Hospital, Jerusalem, Israel
Abstract:
Keywords:Cirrhosis  Liver transplantation  Vaccine  Influenza  COVID-19  SARS-CoV-2
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号